News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Wound Care Company Regenesis Biomedical Raises $527K In Series B
September 5, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Regenesis Biomedical Inc., a developer of wound healing acceleration products, has raised $527,500 in in a first close of its Series B financing, according to a filing with the Securities and Exchange Commission.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Obesity
Lilly’s Weight Loss Trio Could Top $100B in Revenue Thanks to Oral Option
November 19, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
UPDATE: Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting Lundbeck
November 19, 2025
·
3 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition
November 18, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Nxera’s Quest for Profitability Claims 15% of Workforce
November 18, 2025
·
2 min read
·
Tristan Manalac
